Rights Issue

Genesys International Rights Issue 2026 — ₹50 Price, 3:5 Ratio, Full Details

Genesys International Rights Issue 2026 — ₹50 Price, 3:5 Ratio, Full Details

1. Rights Issue Highlights

CompanyGenesys International Corporation Limited
ExchangesBSE: 506109 | NSE: GENESYS
InstrumentFully paid-up equity rights shares (Face Value ₹5)
Rights Price₹50 per share (₹5 face + ₹45 premium)
Entitlement Ratio3 : 5 (3 rights shares for every 5 held)
Issue Size₹12,537.11 lakhs (≈ ₹125.37 crore)
Shares Offered2,50,74,226 equity shares
Record Date6 August 2026 (Thursday)
Issue Window14 August 2026 – 21 August 2026
On-market Renunciation14 August 2026 – 18 August 2026
RegistrarBigshare Services Private Limited
RE ISININE727B20018 (Equity ISIN: INE727B01026)
Market Price (ref.)≈ ₹193.20 (NSE close, 14 Aug 2026) — derived discount ~74%

Discount and market price are derived from the disclosed rights price and the latest available close; these figures move with the market.

2. About the Company

Incorporated in 1983 and headquartered in Mumbai, Genesys International is a geospatial technology company. Its work spans photogrammetry, remote sensing, LiDAR surveys, GIS data, high-precision 3D digital-twin maps and navigation content. Clients include government bodies, infrastructure, utilities and automotive/mobility firms. Notable engagements include the Mumbai 3D City Model and Saudi Arabia's NEOM programme, and it launched India's first AI navigation map in FY2025. A ₹110 crore QIP was completed in May 2025. Growth depends on large, often government-linked, project pipelines, while future outlook rests on execution and monetising its map data assets.

3. What is This Rights Issue?

A rights issue lets a listed company raise capital by offering additional shares to its existing shareholders, in proportion to what they already own, usually at a set price. Here, Genesys International is offering 3 new shares for every 5 held on the record date, at ₹50 each. Eligible holders can apply for their entitlement, apply for more, let it lapse, or sell (renounce) it on the exchange. It is a corporate action, not a public IPO.

4. Important Dates

EventDate
Board approval26 June 2026
Terms fixed (Rights Issue Committee)31 July 2026
Record Date6 August 2026
Ex-Date (derived, T+1)6 August 2026 (last cum-rights day 5 Aug)
Issue Opens14 August 2026
On-market Renunciation ends18 August 2026
Issue Closes21 August 2026 (extendable up to 30 days)

The company's filing did not separately state an ex-date; it is shown per the standard T+1 convention. Off-market renunciation last date: Not Disclosed by the Company.

5. Rights Issue Timeline

Approval to record date: the Board cleared the issue on 26 June, the committee fixed price and ratio on 31 July, and the 6 August record date locked in who is eligible.

Subscription to allotment: the window runs 14–21 August, with rights trading closing 18 August. Allotment, credit and listing of new shares follow after the issue closes, as confirmed by the registrar.

6. Issue Structure

Price & face value: ₹50 per share on a ₹5 face value, so ₹45 is share premium. Ratio: 3 rights shares for every 5 held.

Size & capital impact: 2,50,74,226 new shares raise up to ₹125.37 crore. Paid-up shares rise from 4,17,90,377 to 6,68,64,603 on full subscription — about a 60% increase in the share count.

7. Objects of the Issue

The 31 July outcome letter routed detailed objects to the Letter of Offer. Per the offer document and exchange reporting, proceeds are earmarked for: (a) working capital to support project execution; (b) general corporate purposes; and (c) conversion of about ₹14.89 crore of promoter unsecured loans into equity, which reduces promoter debt on the books. Investors should confirm the exact object-wise break-up in the Letter of Offer.

8. Promoter Participation

Before: promoter and promoter group holding was around 31.5% (June 2026 quarter). Reporting indicates promoters intend to subscribe fully.

After: the exact post-issue promoter percentage is Not Disclosed by the Company. Full participation plus loan-to-equity conversion could raise the promoter stake, signalling commitment but also limiting how much fresh public capital is raised.

9. Financial Performance

FY26 consolidated revenue was about ₹328 crore (₹32,780.89 lakhs), up roughly 5% year on year, while profit fell around 42% to about ₹32.8 crore. Return on equity has averaged near 7% over three years, and the company has not paid dividends. Multi-year metrics such as EPS, book value, ROCE, interest coverage and cash flow trends should be read directly from the audited filings and the Letter of Offer.

10. Financial Analysis

The topline is growing modestly, but the sharp FY26 profit drop points to margin and cost pressure, and quarterly earnings have been lumpy — a common feature of milestone-billed, project-heavy businesses. High receivable days (reported near 226) tie up cash and help explain the working-capital focus of this issue. A modest ROE alongside a rich historical valuation means the market has been pricing future growth rather than current returns; investors should weigh execution consistency against that expectation.

11. Balance Sheet Analysis

Fresh equity plus the loan-to-equity conversion should strengthen net worth and lower promoter-related debt, improving financial flexibility. Authorised capital was raised to ₹45 crore in April 2026 to accommodate the expansion. Detailed line items — total debt, reserves, receivables and fixed assets — should be verified in the latest audited balance sheet.

12. Cash Flow Analysis

Elevated debtor days suggest operating cash conversion can lag reported profit, a key reason working capital features among the objects. The rights proceeds add a financing inflow that can ease this gap. Operating, investing and financing cash-flow specifics are Not Disclosed by the Company in the outcome letter and should be reviewed in the annual report.

13. Shareholding Pattern

Before: promoters ~31.5% and public ~68.5% (June 2026 quarter).

After: exact post-issue split is Not Disclosed by the Company; it depends on take-up. Impact: shareholders who don't apply see their percentage ownership fall as the share count grows ~60%.

Verify the final post-issue shareholding pattern against BSE/NSE filings before publication.

14. Industry Analysis

Geospatial and location intelligence is a structurally expanding market, powered by smart cities, digital public infrastructure, drones/LiDAR liberalisation and demand for high-definition maps in mobility. Opportunities include government digitisation and 3D digital twins; threats include global mapping majors, open-data alternatives, long project cycles and reliance on public-sector budgets. Precise market-size figures should be sourced from current industry reports.

15. Competitive Position

Genesys is among India's established geospatial specialists, with in-house LiDAR/photogrammetry capability, a large proprietary map database and marquee references such as the Mumbai 3D City Model and NEOM. Its edge lies in domain depth and long-cycle project execution; the trade-off is customer concentration and dependence on government-linked demand, which management has cited as areas of active diversification.

16. Growth Drivers

Key drivers include India's smart-city and urban-mapping push, monetisation of the AI navigation map and 3D digital-twin platforms, overseas expansion via the Saudi subsidiary and GEOSA/Survey of India collaborations, and recurring GIS/data-maintenance contracts. Fresh capital from the rights issue can fund working capital to convert this pipeline into billed revenue.

17. Risk Factors

Earnings volatility: profit fell sharply in FY26 and quarterly results have swung, adding uncertainty.

Working capital: high receivable days can strain cash flow and lift funding needs.

Concentration: dependence on government/large projects exposes revenue to budget and timing risk.

Dilution & price: a ~60% share increase dilutes non-applicants, and the market price has fallen steeply over the past year.

18. Opportunities

A stronger balance sheet and lower promoter debt could improve financial flexibility to bid for and deliver larger contracts. Scaling the AI map, digital-twin and overseas geospatial business, plus recurring data-maintenance revenue, offers a path to steadier earnings if execution and collections improve.

19. Advantages (Pros)

Discounted entry (conditional): ₹50 is far below the recent market price. This matters because participants add shares cheaply; it benefits eligible holders who apply. It may not apply because the price adjusts for the entitlement — the discount is not a guaranteed profit.

Maintain ownership: applying lets existing shareholders keep their proportional stake. It matters because those who skip get diluted. It benefits participating holders; it doesn't help renouncers or non-applicants.

Capital for the business: proceeds fund working capital and reduce promoter loans, potentially aiding growth. It benefits the company and long-term holders — but only if funds are deployed productively.

Stronger balance sheet & promoter signal: loan-to-equity conversion cuts debt, and full promoter subscription can signal commitment. It benefits all shareholders via lower leverage; the benefit fades if operating performance stays weak.

20. Disadvantages (Cons)

Equity dilution: the share count rises ~60%. Non-applicants own a smaller slice and may see EPS pressured. Evaluate whether your entitlement offsets the dilution you'd otherwise absorb.

Capital-loss & execution risk: more money committed means more at stake if project delivery or collections disappoint. Judge it against the FY26 profit decline and receivable levels.

Volatility & liquidity: the stock has fallen sharply over a year and can be volatile. Renunciation value and post-issue price are not guaranteed; assess your own time horizon.

Fund-use & subscription risk: value depends on how proceeds are used; a large share of promoter-loan conversion means less pure growth capital. Weigh the stated objects carefully.

21. Should Existing Shareholders Apply?

This is a personal decision, and this article makes no recommendation. Factors shareholders often weigh include valuation after the price adjusts for the entitlement, the company's fundamentals and FY26 profit trend, the intended use of proceeds (working capital, general purposes, promoter-loan conversion), the balance-sheet position and receivables, the geospatial industry outlook, and one's own risk appetite and time horizon. Those who don't wish to add capital may consider renouncing the entitlement during the on-market window rather than letting it lapse. Reading the Letter of Offer and consulting a SEBI-registered adviser is prudent.

22. Investor Insights

The headline discount is eye-catching, but a deeply discounted rights issue mainly redistributes value between participants and non-participants — the ex-rights price falls to reflect the new, cheaper shares. The more decision-relevant questions are whether the fresh capital fixes the working-capital bottleneck, whether FY26's profit dip is temporary, and how much of the raise is genuinely growth capital versus loan conversion. Track the subscription figures during the window as a real-time read on demand.

23. Analyst Perspective

On a neutral, fact-based reading, Genesys operates in a growing geospatial market with strong references but faces near-term earnings softness, working-capital intensity and customer concentration. The rights issue improves capital structure and shows promoter participation, yet dilution and execution risk remain. Views differ across market observers, and past price moves do not indicate future returns; this section is educational, not a rating.

24. Conclusion

Genesys International's 2026 rights issue offers 3 shares for every 5 held at ₹50 each, aiming to raise about ₹125.37 crore from eligible shareholders as on the 6 August record date, with subscription open 14–21 August. The most striking feature is the steep gap between the ₹50 price and the recent market price near ₹193 — a discount that looks generous but largely washes out once the price adjusts for the entitlement and the share count rises around 60%. For the business, the raise strengthens the balance sheet, adds working capital and converts promoter debt to equity. For shareholders, the core trade-off is between committing more capital to a firm with a promising but volatile geospatial franchise and accepting dilution if they stay out. The sensible path is to read the Letter of Offer, verify subscription and shareholding data on BSE/NSE, and align any action with personal objectives. This is educational content only and not investment advice.

Frequently Asked Questions (FAQ)

What is a rights issue?
A rights issue is a corporate action in which a listed company offers new shares to its existing shareholders in proportion to their current holding, usually at a fixed price. It raises fresh capital while giving current owners the first chance to participate.
Who is eligible for the Genesys International rights issue?
Shareholders whose names appear in the company's records as on the record date, 6 August 2026, are eligible to receive the rights entitlement.
What is the record date and why does it matter?
The record date is 6 August 2026. It is the cut-off used to identify which shareholders are entitled to apply. If you were not a holder by then, you cannot receive a direct entitlement.
What is the ex-date for this issue?
The company's filing did not separately state an ex-date. Under the T+1 settlement convention, the last cum-rights trading day was 5 August 2026, and the shares trade ex-rights from the record date. Confirm the exchange's official ex-date if precision is needed.
What is the rights entitlement ratio?
The ratio is 3:5 — three new rights shares for every five fully paid-up shares held on the record date.
Can I trade my rights entitlement?
Yes. Rights entitlements (RE, ISIN INE727B20018) can typically be traded on the exchange during the on-market renunciation window, which runs 14–18 August 2026 for this issue.
What is renunciation?
Renunciation means transferring your right to apply to someone else, either on the market or off-market, instead of subscribing yourself. It lets a shareholder who does not want to invest realise some value from the entitlement.
What is the issue price?
₹50 per rights share, comprising the ₹5 face value plus a ₹45 premium.
How big is the discount to the market price?
Against the last available close of about ₹193.20 (NSE, 14 August 2026), ₹50 is roughly a 74% discount. This is a derived figure that changes with the market, and the price mechanically adjusts for the entitlement, so the discount is not a guaranteed gain.
How are rights shares taxed?
In general, subscribing to rights shares is not itself a taxable event; capital gains apply when you eventually sell, with the holding period counted from allotment. Selling a renounced entitlement can have its own tax treatment. Tax rules vary by individual — consult a qualified tax adviser.
What are the potential benefits of applying?
Participants can add shares at the fixed price, maintain their proportional ownership, and support a capital raise intended for working capital and debt reduction. Benefits depend on the company using the funds well and on future performance.
What are the main risks?
Risks include dilution for non-applicants, a sharp FY26 profit decline, high receivable days, dependence on large/government projects, and share-price volatility. More capital committed also means more potential loss if performance weakens.
How does the issue dilute my holding?
On full subscription the share count rises from 4,17,90,377 to 6,68,64,603 — about 60% more shares. Shareholders who do not apply will own a smaller percentage of the company afterward.
How do I apply for the rights issue?
Eligible shareholders can apply through the ASBA facility via net banking, or through the registrar's R-WAP portal where available. Applications are made during the issue window, 14–21 August 2026.
Can I apply for more than my entitlement?
Yes, shareholders may apply for additional shares over their entitlement. Allotment of extra shares is not guaranteed and depends on availability after entitlement allotments, as set out in the offer terms.
When will the shares be credited?
Allotment and credit to demat accounts happen after the issue closes, per the registrar's schedule. Exact allotment, credit and listing dates should be confirmed with Bigshare Services and the exchanges.
What about refunds?
Because ASBA blocks funds rather than debiting them upfront, money for un-allotted additional shares is simply unblocked in your bank account, so a separate refund is generally not required.
Where will the new shares be listed?
The company's equity is listed on BSE (506109) and NSE (GENESYS). The new rights shares are expected to be listed and become tradable after allotment.
Are promoters participating?
Reporting indicates promoters intend to subscribe fully, and around ₹14.89 crore of promoter unsecured loans is set to convert into equity. The exact post-issue promoter percentage is Not Disclosed by the Company.
How does a rights issue affect the share price?
On the ex-rights date the price typically adjusts downward to reflect the new, lower-priced shares (the theoretical ex-rights price). After that, the price moves with demand, results and market sentiment.
What should retail investors keep in mind?
Retail investors should read the Letter of Offer, understand the objects of the issue, note the FY26 earnings trend and working-capital position, track live subscription data, and decide based on their own goals and risk tolerance rather than the headline discount.
What are the options for existing shareholders who don't want to invest?
They can renounce (sell) the entitlement on the exchange during the renunciation window to try to recover some value, or let it lapse — in which case they receive nothing for it and their stake gets diluted.
Share this update
Back to Corporate Actions

Explore More Investment Opportunities

Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.